On April 2, Virpax Pharmaceuticals Inc Got Letter From Nasdaq Stating That Company Was Not In Compliance With Nasdaq Listing Rule
4月2日,Virpax Pharmicals Inc收到納斯達克的來信,稱該公司未遵守納斯達克上市規則
On April 2, Virpax Pharmaceuticals Inc Got Letter From Nasdaq Stating That Company Was Not In Compliance With Nasdaq Listing Rule
4月2日,Virpax Pharmicals Inc收到納斯達克的來信,稱該公司未遵守納斯達克上市規則
使用瀏覽器的分享功能,分享給你的好友吧